Chemoinformaics analysis of 2,5,9-Trimethyl-4,9-decadienal
| Molecular Weight | 194.318 | nRot | 7 |
| Heavy Atom Molecular Weight | 172.142 | nRig | 3 |
| Exact Molecular Weight | 194.167 | nRing | 0 |
| Solubility: LogS | -3.496 | nHRing | 0 |
| Solubility: LogP | 3.475 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 37.1814 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.443 |
| Synth | 3.516 |
| Natural Product Likeliness | 2.253 |
| NR-PPAR-gamma | 0.372 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.477 |
| MDCK | 0.0000223 |
| BBB | 0.984 |
| PPB | 0.690687 |
| VDSS | 2.566 |
| FU | 0.253933 |
| CYP1A2-inh | 0.185 |
| CYP1A2-sub | 0.482 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.384 |
| CYP2c9-inh | 0.025 |
| CYP2c9-sub | 0.673 |
| CYP2d6-inh | 0.234 |
| CYP2d6-sub | 0.645 |
| CYP3a4-inh | 0.096 |
| CYP3a4-sub | 0.204 |
| CL | 7.209 |
| T12 | 0.683 |
| hERG | 0.006 |
| Ames | 0.004 |
| ROA | 0.001 |
| SkinSen | 0.972 |
| Carcinogencity | 0.071 |
| EI | 0.989 |
| Respiratory | 0.237 |
| NR-Aromatase | 0.02 |
| Antiviral | Yes |
| Prediction | 0.638134 |